0001415889-24-017009.txt : 20240614
0001415889-24-017009.hdr.sgml : 20240614
20240614180505
ACCESSION NUMBER: 0001415889-24-017009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240614
DATE AS OF CHANGE: 20240614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAAB MICHAEL
CENTRAL INDEX KEY: 0001321402
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 241046318
MAIL ADDRESS:
STREET 1: 1119 ST PAUL STREET
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tempest Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-798-8589
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Millendo Therapeutics, Inc.
DATE OF NAME CHANGE: 20181207
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
form4-06142024_060601.xml
X0508
4
2024-06-13
0001544227
Tempest Therapeutics, Inc.
TPST
0001321402
RAAB MICHAEL
C/O TEMPEST THERAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE
CA
94005
true
false
false
false
0
Stock Option (right to buy)
3.03
2024-06-13
4
A
0
16000
0
A
2034-06-12
Common Stock
16000
16000
D
The shares underlying the option will vest in full on the earlier of (i) June 13, 2025, or (ii) the day of the Issuer's 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.
/s/ Nicholas Maestas, Attorney-in-Fact for Michael Raab
2024-06-14